Does NITROGLYCERIN Cause Malignant neoplasm progression? 5 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Malignant neoplasm progression have been filed in association with NITROGLYCERIN (Glonoinum). This represents 0.1% of all adverse event reports for NITROGLYCERIN.
5
Reports of Malignant neoplasm progression with NITROGLYCERIN
0.1%
of all NITROGLYCERIN reports
0
Deaths
4
Hospitalizations
How Dangerous Is Malignant neoplasm progression From NITROGLYCERIN?
Of the 5 reports, 4 (80.0%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NITROGLYCERIN. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does NITROGLYCERIN Cause?
Drug ineffective (1,269)
Fall (1,183)
Hypotension (1,086)
Pain (952)
Constipation (896)
Headache (890)
Dyspnoea (801)
Malaise (765)
Dizziness (717)
Fatigue (680)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which NITROGLYCERIN Alternatives Have Lower Malignant neoplasm progression Risk?
NITROGLYCERIN vs NITROUS
NITROGLYCERIN vs NITROUS\OXYGEN
NITROGLYCERIN vs NIVOLUMAB
NITROGLYCERIN vs NIVOLUMAB\RELATLIMAB-RMBW
NITROGLYCERIN vs NIZATIDINE